Maker of weed-killer Roundup gets change-of-venue win in cases that contend product causes disease
A federal court judge in San Francisco has handed Monsanto a big victory in its bid to ward off large money verdicts in trials alleging that its Roundup weed-killer causes cancer.
According to a recent online Courthouse News Service story by Helen Christophi, U.S. District Judge Vince Chhabria is giving the agribusiness a chance to pick the venue of upcoming trials.
Monsanto, which is owned by Bayer AG, had sought to have the trials take place "in agricultural states where farmers heavily depend on the company's glyphosate-based herbicides Roundup and Ranger Pro, and where medical-causation laws favor the defendants," the article explains.
Chhabria oversees nationwide litigation over the product.
Aimee Wagstaff of the Colorado law firm Andrus Wagstaff has been representing the plaintiffs.
The judge's ruling followed Monsanto losing three trials in a row in California courts in which plaintiffs testified that they developed non-Hodgkin's lymphoma after using Roundup.
The World Health Organization's cancer agency in 2015 had declared the weed-killer's main ingredient, glyphosate, a probable human carcinogen.
Chhabria also postponed the next bellwether case until Feb. 10 of next year. It had been scheduled to start this month.
More information on litigation regarding products that may cause disease can be found in "Rollercoaster: How a man can survive his partner's breast cancer," a VitalityPress book that I, Woody Weingarten, aimed at male caregivers.